checkAd

    DGAP-News  123  0 Kommentare Epigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders - Seite 3


    27.04.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.dgap.de

    Language: English
    Company: Epigenomics AG
    Geneststraße 5
    10829 Berlin
    Germany
    Phone: +49 30 24345-0
    Fax: +49 30 24345-555
    E-mail: ir@epigenomics.com
    Internet: www.epigenomics.com
    ISIN: DE000A3H2184
    WKN: A3H218
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 1189515

     
    End of News DGAP News Service

    Lesen Sie auch

    1189515  27.04.2021 

    fncls.ssp?fn=show_t_gif&application_id=1189515&application_name=news&site_id=wallstreet
    Seite 3 von 3



    Diskutieren Sie über die enthaltenen Werte



    EQS Group AG
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von EQS Group AG
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    DGAP-News Epigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders - Seite 3 DGAP-News: Epigenomics AG / Key word(s): Capital Increase Epigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders 27.04.2021 / 17:40 The issuer is solely responsible for the content …